Because No One is Immune to the Law
January 31, 2022 - United States, Digital Health, Biotech, Healthcare, Pharma

RECORDINGS NOW AVAILABLE: 2022 LIFE SCIENCES MOFORUM – GROWTH, INNOVATION, AND STRATEGY

Life Sciences + Healthcare

Last week, Morrison & Foerster’s Life Sciences & Healthcare Group hosted its first program of the year with the firm’s 2022 Life Sciences MOFORUM – Growth, Innovation, and Strategy. We welcomed 100+ participants over the three-day virtual program to hear from leaders from across the biotechnology, digital health, and healthcare ecosystems on what is driving the industry forward and the challenges and opportunities for new innovation across the sector.

Recordings from Day 1 and Day 2 of our program are now available.

Digital Transformation in the Life Sciences

Moderated by: Brigid Bondoc, Of Counsel, FDA Regulatory and Compliance practice

Panelists:

  • Melinda Decker, Digital Health Advisor and former Chief Commercial Officer, Mymee
  • Chris Bergstrom, President, Amalgam Rx
  • Laura Taraboanta, Sr. Manager, Head of Clinical Innovations, Click Therapeutics
  • Shaheen Lakhan, Chief Medical Officer, Click Therapeutics

 

 

The Future of Drug Discovery and Diagnostics

Moderated by: Matthew Karlyn, Partner, Life Sciences Transactions & Licensing practice

Panelists:

  • Scott Carter, Assistant General Counsel, BeiGene
  • Michelle Egger, Co-founder & CEO, BIOMILQ
  • Daniel Oliver, Co-founder & CEO, Rejuvenate Bio
  • William W. Li, M.D., President and Medical Director, The Angiogenesis Foundation